GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM31571
Query DataSets for GSM31571
Status
Public on Oct 07, 2004
Title
CNS-SpinalCmod-Adult-4h-4B-s2
Sample type
RNA
Source name
Rat spinal cord Injury site
Organism
Rattus norvegicus
Extracted molecule
total RNA
Description
Expression profiling of spinal cord section (T9) extracted from rats 4h following moderate injury
Submission date
Sep 30, 2004
Last update date
Oct 01, 2019
Contact name
Eric P Hoffman
E-mail(s)
[email protected]
Organization name
Binghamton University - SUNY
Department
Pharmaceutical Sciences
Street address
PO Box 6000
City
Binghamton
State/province
NY
ZIP/Postal code
13902
Country
USA
Platform ID
GPL86
Series (1)
GSE464
CNS Regeneration
Data table header descriptions
ID_REF
VALUE
SIGNAL (See Affymetrix Literature)
ABS_CALL
Presence or Absence of gene transcript in sample
Data table
ID_REF
VALUE
ABS_CALL
AFFX-BioB-3_at
681.1771240234375
P
AFFX-BioB-3_st
42.1240348815918
A
AFFX-BioB-5_at
815.8435668945312
A
AFFX-BioB-5_st
140.21653747558594
A
AFFX-BioB-M_at
1265.478759765625
P
AFFX-BioB-M_st
234.0631866455078
A
AFFX-BioC-3_at
1706.7349853515625
P
AFFX-BioC-3_st
55.17892074584961
A
AFFX-BioC-5_at
3462.18798828125
P
AFFX-BioC-5_st
45.33897399902344
A
AFFX-BioDn-3_at
15659.408203125
P
AFFX-BioDn-3_st
253.60523986816406
A
AFFX-BioDn-5_at
2279.325439453125
P
AFFX-BioDn-5_st
338.54693603515625
A
AFFX-CreX-3_at
36287.8203125
P
AFFX-CreX-3_st
728.0200805664062
A
AFFX-CreX-5_at
28468.033203125
P
AFFX-CreX-5_st
510.3630065917969
P
AFFX-DapX-3_at
29.354185104370117
A
AFFX-DapX-5_at
38.989219665527344
A
Total number of rows:
8791
Table truncated, full table size
301 Kbytes
.
Supplementary file
Size
Download
File type/resource
GSM31571.CEL.gz
2.0 Mb
(ftp)
(http)
CEL
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|
